H&R GmbH KGaA (WBO:2HRA) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:2HRA H&R GmbH & Co KGaA WBO:2HRA
40 GF Score
Price €6.46
GF Value €4.25
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is H&R GmbH KGaA FFO?

FFO (Funds from operations) only applies to REITs.

WBO:2HRA
40GF Score
H&R GmbH & Co KGaA WBO:2HRA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?

Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued. The current stock price of €6.46 is trading 52% above its estimated GF Value™ of €4.25. GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.

Key valuation signals for WBO:2HRA:

  • FFO:
  • GF Value™: €4.25 vs. price of €6.46 (52% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H&R GmbH KGaA Business Description

Other Exchanges 0RRC:UK2HRA:Germany
Address Neuenkirchener Strasse 8, Salzbergen, NI, DEU, 48499
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
40GF Score

Get the complete analysis for WBO:2HRA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.46
Price
€4.25
GF Value